Categories Companies

Loading the SOTA2 catalog…

Explore

Categories Companies

Contribute

Join SOTA2 Contact

SOTA2

© 2026 SOTA2

Build in Bellevue, USA

NYB

AI-first drug discovery and nutraceuticals company that advances therapeutics and nutraceuticals through an integrated discovery platform.

VisitClaim or join

Founded: Not disclosed
Headquarters: Not disclosed
Company size: Not disclosed
Products tracked: 4

Products by NYB

4 products

VecuraAgentic AI compound discovery platform that unifies proprietary AI models, curated natural datasets, and scientific workflows into a single connected environment.0.00 reviewsDrug Discovery & Biotech

VecurateProprietary digital natural compound library of 1.5M+ compounds from over 50,000 underexplored species, integrating biology, chemistry, and traditional usage for discovery insig...0.00 reviewsDrug Discovery & Biotech

DTIGN (Drug-Target Interaction Graph Network)Proprietary AI model for bioactivity prediction using graph neural networks, outperforming nine leading methods by an average of 27.03% in bioactivity prediction correlation.0.00 reviewsDrug Discovery & Biotech

Nutraceutical Innovation PlatformEnd-to-end nutraceutical research and formulation platform providing mechanism-guided formulation, AI-assisted tools, preclinical evaluation, formulation development, and OEM/cu...0.00 reviewsDrug Discovery & Biotech

Pricing for NYB

Contact NYB for current plans, volume pricing, and enterprise terms.

Trust profile

Security and compliance

No compliance claims have been published for this company.

Product portfolio

Markets

Healthcare & Life Sciences4 Models & AI Infrastructure1 Data & Analytics1

Industries served

Healthcare & Life Sciences1

Company details Public record

Website: nyb.group
Deployment: Self-hosted, On-premises